SAGE THERAPEUTICS INC's ticker is SAGE and the CUSIP is 78667J108. A total of 214 filers reported holding SAGE THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 0.42 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $1,533,087 | -64.8% | 32,605 | -68.6% | 0.01% | -66.7% |
| Q1 2023 | $4,352,553 | +117759.5% | 103,731 | +7.1% | 0.02% | +15.4% |
| Q4 2022 | $3,693 | -99.9% | 96,834 | 0.0% | 0.01% | -13.3% |
| Q3 2022 | $3,792,000 | -32.7% | 96,834 | -44.5% | 0.02% | -28.6% |
| Q2 2022 | $5,635,000 | +297.1% | 174,451 | +444.9% | 0.02% | +320.0% |
| Q3 2021 | $1,419,000 | +5.3% | 32,017 | +35.0% | 0.01% | 0.0% |
| Q2 2021 | $1,347,000 | +12.7% | 23,717 | +48.6% | 0.01% | 0.0% |
| Q1 2021 | $1,195,000 | – | 15,960 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Integral Health Asset Management, LLC | 311,000 | $10,294,000 | 2.68% |
| Palo Alto Investors LP | 851,719 | $28,192,000 | 2.18% |
| Boxer Capital, LLC | 1,094,000 | $36,211,000 | 1.86% |
| DAFNA Capital Management LLC | 180,306 | $5,968,000 | 1.56% |
| Deep Track Capital, LP | 675,000 | $22,343,000 | 1.43% |
| Bellevue Group AG | 3,052,404 | $101,034,000 | 1.17% |
| Ikarian Capital, LLC | 249,907 | $8,272,000 | 1.09% |
| Ikarian Capital, LLC | 250,000 | $8,275,000 | 1.09% |
| Artal Group S.A. | 750,000 | $24,825,000 | 1.04% |
| SECTOR GAMMA AS | 118,476 | $3,922,000 | 0.85% |